Progress in Drug Research/Fortschritte Der Arzneimittelforschung/Progrès Des Recherches Pharmaceutiques 1996
DOI: 10.1007/978-3-0348-8998-8_3
|View full text |Cite
|
Sign up to set email alerts
|

Subclassification and nomenclature of α1- and α2-adrenoceptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

3
33
0

Year Published

1997
1997
2015
2015

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(36 citation statements)
references
References 73 publications
3
33
0
Order By: Relevance
“…The considerably attenuated ␣ 2 ARagonist-induced inhibition of Ca 2ϩ currents in SCG neurons from mutant mice was completely suppressed by prazosin (Fig. 5F), an ␣ 1 AR antagonist that also blocks ␣ 2B AR and ␣ 2C AR subtypes (but not the ␣ 2A AR subtype) with reasonably high potency (5), suggesting that the residual voltage-gated Ca 2ϩ current response to ␣ 2 AR agonists in neurons from D79N mice is mediated by ␣ 2B and͞or ␣ 2C AR subtype. Thus, the D79N mutant ␣ 2A AR is unable to evoke inhibition of voltage-gated Ca 2ϩ currents in SCG neurons, similar to the loss of responses observed in LC neurons derived from D79N mutant mice.…”
Section: Resultsmentioning
confidence: 93%
See 2 more Smart Citations
“…The considerably attenuated ␣ 2 ARagonist-induced inhibition of Ca 2ϩ currents in SCG neurons from mutant mice was completely suppressed by prazosin (Fig. 5F), an ␣ 1 AR antagonist that also blocks ␣ 2B AR and ␣ 2C AR subtypes (but not the ␣ 2A AR subtype) with reasonably high potency (5), suggesting that the residual voltage-gated Ca 2ϩ current response to ␣ 2 AR agonists in neurons from D79N mice is mediated by ␣ 2B and͞or ␣ 2C AR subtype. Thus, the D79N mutant ␣ 2A AR is unable to evoke inhibition of voltage-gated Ca 2ϩ currents in SCG neurons, similar to the loss of responses observed in LC neurons derived from D79N mutant mice.…”
Section: Resultsmentioning
confidence: 93%
“…Subtype-specific ␣ 2 AR agonists and antagonists are not available (5); even when subtype selectivity has been noted in vitro, varying and unknown in vivo bioavailability precludes confident correlation of the administered dose with the amount of drug at the receptor site. Previous studies to explore ␣ 2 AR involvement in various responses have used prazosin to block catecholamine responses mediated by ␣ 1 adrenergic receptors (␣ 1 AR); however, it is now known that the ␣ 2B AR and ␣ 2C AR subtypes also are blocked by prazosin (5), thus confounding the interpretations of these earlier studies.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Many cellular responses to ␣ 1 ARs are mediated by multiple subtypes (␣ 1A , ␣ 1B , and ␣ 1D ) (1)(2)(3)(4). In the heart, whereas the ␣ 1A and ␣ 1B subtypes have been well characterized, the presence of ␣ 1D AdR was indicated only recently (5)(6)(7).…”
mentioning
confidence: 99%
“…They regulate blood pressure by changing the tonus of the vascular muscles. According to the current classification developed by the International Union of Pharmacology Subcommittee on Nomenclature for Adrenoceptors, there are three subtypes of α 1 -adrenergic receptor: α 1A , α 1B , α 1D (Hieble and Ruffolo 1996;Docherty 1998;Langer 1999).…”
mentioning
confidence: 99%